ScholarIQanswers from OpenAlex & ORCID
James Chih‐Hsin Yang
ResearcherPublications, citations & collaboration network
James Chih‐Hsin Yang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James Chih‐Hsin Yang have?
ScholarIQindexed works
James Chih‐Hsin Yang has 1,101 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James Chih‐Hsin Yang have?
ScholarIQcitation count
James Chih‐Hsin Yang has 92,257 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James Chih‐Hsin Yang?
ScholarIQh-index
James Chih‐Hsin Yang has an h-index of 133 in OpenAlex.
What is the i10-index of James Chih‐Hsin Yang?
ScholarIQi10-index
James Chih‐Hsin Yang has an i10-index of 486 in OpenAlex.
What is the ORCID of James Chih‐Hsin Yang?
ScholarIQorcid
The ORCID for James Chih‐Hsin Yang is on the source record.
What is the OpenAlex record for James Chih‐Hsin Yang?
ScholarIQopenalex
The OpenAlex for James Chih‐Hsin Yang is on the source record.
What are the most-cited papers on James Chih‐Hsin Yang?
ScholarIQmost cited works
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
Lecia V. Sequist, James Chih‐Hsin Yang, Nobuyuki Yamamoto, Kenneth J. O’Byrne, Vera Hirsh, Tony Mok, Sarayut Lucien Geater, С. В. Орлов, Chun‐Ming Tsai, Michael Boyer, Wu‐Chou Su, Jaafar Bennouna, Terufumi Kato, В. А. Горбунова, Ki Hyeong Lee, Riyaz Shah, Dan Massey, Victoria Zazulina, Mehdi Shahidi, Martin Schüler
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, James Chih‐Hsin Yang, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Richard M. Sherry, Nicholas P. Restifo, Amy M. Hubicki, Michael R. Robinson, Mark Raffeld, Paul H. Duray, Claudia A. Seipp, Linda Rogers-Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White, Steven A. Rosenberg
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Seth M. Steinberg, Helen X. Chen, Steven A. Rosenberg
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Marybeth S. Hughes, James Chih‐Hsin Yang, Richard M. Sherry, Richard E. Royal, Suzanne L. Topalian, Udai S. Kammula, Nicholas P. Restifo, Zhili Zheng, Azam Nahvi, Christiaan R. de Vries, Linda Rogers-Freezer, Sharon Mavroukakis, Steven A. Rosenberg
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
Steven A. Rosenberg, Beverly S. Packard, Paul Aebersold, Diane Solomon, Suzanne L. Topalian, Stephen T. Toy, Paul Simon, Michael T. Lotze, James Chih‐Hsin Yang, Claudia A. Seipp, Colleen Simpson, Charles W. Carter, Steven Bock, Douglas J. Schwartzentruber, John P. Wei, Donald E. White